The main objective of this undertaking is to investigate the possibility of using the EURIPID database as a data source for the calculation of Purchasing Power Parities (PPPs) for pharmaceutical products, including analysing all advantages and disadvantages compared to the existing methodology, as well as making test PPP calculations using different models, for the years 2015, 2016 and 2017.The proposed study aims to identify a new methodological approach based on the features of the EURIPID database in close collaboration between the members of the EURIPID Collaboration and EUROSTAT experts. In the course of this pilot study, different options of calculation were developed, tested and critically reflected together.